Orgenesis Financials

Orgenesis Stock Summary

Orgenesis competes with Helix BioMedix, and Next Generation. Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland. Orgenesis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.

Orgenesis Key Financial Ratios

There are many critical financial ratios that Orgenesis' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Orgenesis reports annually and quarterly.

Orgenesis Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Orgenesis's current stock value. Our valuation model uses many indicators to compare Orgenesis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orgenesis competition to find correlations between indicators driving Orgenesis's intrinsic value. More Info.Orgenesis is regarded third in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orgenesis' earnings, one of the primary drivers of an investment's value.

Along with financial statement analysis, the daily predictive indicators of Orgenesis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orgenesis. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orgenesis based on widely used predictive technical indicators. In general, we focus on analyzing Orgenesis Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orgenesis's daily price indicators and compare them against related drivers.

When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.